BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32244387)

  • 1. Rifamycin O, An Alternative Anti-
    Hanh BTB; Park JW; Kim TH; Kim JS; Yang CS; Jang K; Cui J; Oh DC; Jang J
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32244387
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 4. Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus.
    Ganapathy US; Lan T; Krastel P; Lindman M; Zimmerman MD; Ho H; Sarathy JP; Evans JC; Dartois V; Aldrich CC; Dick T
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0097821. PubMed ID: 34228543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning rifamycins for Mycobacterium abscessus lung disease.
    Ganapathy US; Dartois V; Dick T
    Expert Opin Drug Discov; 2019 Sep; 14(9):867-878. PubMed ID: 31195849
    [No Abstract]   [Full Text] [Related]  

  • 6. Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance.
    Lan T; Ganapathy US; Sharma S; Ahn YM; Zimmerman M; Molodtsov V; Hegde P; Gengenbacher M; Ebright RH; Dartois V; Freundlich JS; Dick T; Aldrich CC
    Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202211498. PubMed ID: 36222275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.
    Johansen MD; Daher W; Roquet-Banères F; Raynaud C; Alcaraz M; Maurer FP; Kremer L
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816730
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of Oritavancin and Its Synergy with Other Antibiotics against
    Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen Box screening for hit identification against Mycobacterium abscessus.
    Jeong J; Kim G; Moon C; Kim HJ; Kim TH; Jang J
    PLoS One; 2018; 13(4):e0195595. PubMed ID: 29698397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant
    Xie M; Ganapathy US; Lan T; Osiecki P; Sarathy JP; Dartois V; Aldrich CC; Dick T
    Antimicrob Agents Chemother; 2023 Sep; 67(9):e0038123. PubMed ID: 37493373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.
    Ramis IB; Figueiredo R; Ramos DF; Halicki PCB; von Groll A; Viveiros M; do Ceu Costa M; da Silva PEA
    Med Chem; 2018; 14(4):394-399. PubMed ID: 29205119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    Rominski A; Roditscheff A; Selchow P; Böttger EC; Sander P
    J Antimicrob Chemother; 2017 Feb; 72(2):376-384. PubMed ID: 27999011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
    Moore RE; Millar BC; Panickar JR; Moore JE
    Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria.
    Combrink KD; Ramos AR; Spring S; Schmidl S; Elizondo K; Morin P; De Jesus B; Maurer FP
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2112-2115. PubMed ID: 31281018
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.